Company Search:
Advanced Search
Sponsored Links
Acceleron Pharma Inc Company Snapshot
Acceleron Pharma Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Acceleron Pharma Inc with three other companies in this sector in UNITED STATES : Editas Medicine Inc (2020 sales of $90.73 million of which 100% was Business operating as a single segment), Twist Bioscience Corp ($90.10 million of which 49% was NGS tools), and Agenus Incorporation ($88.17 million of which 100% was Immuno-oncology).

Sales Analysis. Acceleron Pharma Inc reported sales of $92.52 million for the year ending December of 2020. This represents an increase of 25.0% versus 2019, when the company's sales were $73.99 million. This was the third consecutive year of growth at Acceleron Pharma Inc.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Acceleron Pharma Inc
  Stock Performance Chart for Acceleron Pharma Inc
  Stock Data: Recent Stock Performance:
  Current Price (5/7/2021): 118.18
(Figures in U.S. Dollars)
1 Week -5.4%   13 Weeks -6.8%  
4 Weeks -7.7%   52 Weeks 16.1%  
Acceleron Pharma Inc Key Data:
  Ticker: XLRN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2020 Sales 92,523,000
(Year Ending Jan 2021).
Employees: 312
  Currency: U.S. Dollars Market Cap: 7,166,257,221
  Fiscal Yr Ends: December Shares Outstanding: 60,638,494
  Share Type: Common Closely Held Shares: 7,554,220
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.